(PR-inside.com) NEW YORK, NY / ACCESSWIRE / February 6, 2024 / Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are now investigating: Harpoon Therapeutics, Inc. (NASDAQ:HARP), relating to its proposed sale to Merck. Under the terms of the agreement, HARP shareholders will receive $23.00 in cash per share they own. Click here for more information: https://www.monteverdelaw.com/case/harpoon-therapeutics-inc. It is free and there is no cost or obligation ..
Harpoon is a California-based biotechnology company that researches and develops T-cell immunotherapies for the treatment of cancer and infectious diseases.